NAC SUSTAIN
Natural health product licensed in Canada
- Other names
- N-A-C SUSTAIN
- Licence holder
- Jarrow Formulas Inc.
- NPN or DIN-HM
- 80045652
- Status
- Active licence
- Licence date
- 22 October 2013
- Revision date
- Not provided
- Form
- Comprimé à libération prolongée
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, rouge de betterave, Dioxyde de silicium, Carbomer, Phosphate de calcium, dibasique, Acide stéarique, Carboxyméthylcellulose de sodium, Dextrose, Lécithine, cellulose, citrate de sodium, Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
N-acetyl-L-Cysteine is a potent antioxidant for the maintenance of good health in individuals under oxidative stress. Precursor to the critical antioxidant glutathonine. Precursor for glutathione, the primary cellular antioxidant, to maintain good health. N-Acetyl-L-cysteine promotes the production of glutathione, an important anti-oxidant in the body to maintain good health. N-Acetyl-L-cysteine is a precursor for glutathione, an important anti-oxidant in the body to maintain good health. Helps to relieve the symptoms of chronic bronchitis. Helps reduce the risk of exacerbation and improves symptoms in patients with chronic bronchitis. Helps reduce the frequency of exacerbations in patients with chronic bronchitis. Helps reduce pulmonary exacerbations in patients with chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80045652
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.